| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176307 Group 9 or 10 metal complexes of N-(N-heterocycle-substuted)acridines, phenoxazines and phenothiazines that are capable of converting a triplet excitation state into light emission and excellent in heat resistance; electronic devices with low power consumption |
| 02/13/2007 | US7176306 Hydroxyalkyl cyclic diamine compound |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176227 Amine compounds and use thereof |
| 02/13/2007 | US7176225 For example, (6aR,7aS,8S,11aS)-5,8-bis(dimethylamino)-2-(2,2-diphenylvinyl)-9,11a,12-trihydroxy-11,13-dioxo-6,6a,7,7a,8,11,11a,13-octahydrotetraceno[2,1-d][1,3]oxazole-10-carboxamide; useful against antibiotic resistant organisms |
| 02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 02/13/2007 | US7176200 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/13/2007 | US7175958 Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same |
| 02/13/2007 | CA2463976C N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/13/2007 | CA2254759C Inhibitors of prenyl transferases |
| 02/13/2007 | CA2220649C 4-hydroxy-piperidine derivatives |
| 02/08/2007 | WO2007016674A2 2-aminoaryl pyridines as protein kinases inhibitors |
| 02/08/2007 | WO2007016392A2 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 02/08/2007 | WO2007016354A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/08/2007 | WO2007016292A2 Heterocyclic amides as biofilm modulators |
| 02/08/2007 | WO2007016228A2 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |
| 02/08/2007 | WO2007016212A1 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 02/08/2007 | WO2007016211A1 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 02/08/2007 | WO2007015929A2 Epothilone analogues |
| 02/08/2007 | WO2007015528A1 Agent for treating and/or preventing sleep disorder |
| 02/08/2007 | WO2007014885A1 Antibacterial quinoline derivatives |
| 02/08/2007 | WO2006126171A3 New antibiotic derivatives |
| 02/08/2007 | WO2006123249A3 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 02/08/2007 | WO2006113704A3 Subtituted heteroaryl cb1 antagonists |
| 02/08/2007 | WO2006052810A3 Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/08/2007 | US20070032534 12,13-desoxyepothilones, used as anticarcinogenic agents |
| 02/08/2007 | US20070032531 Sphingosine kinase inhibitors and methods of their use |
| 02/08/2007 | US20070032528 inhibitors of vascular endothelial growth factor receptor tyrosine kinase; antiproliferative agents; antitumor; 4-Hydroxy-3-(5-methylbenzimidazol-2-yl)hydropyridino[3,4-b]pyridin-2-one; nitrogen containing cyclic compounds |
| 02/08/2007 | US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 02/08/2007 | US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia |
| 02/08/2007 | US20070032520 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032508 Quinazoline derivatives as tyrosine kinase inhibitors |
| 02/08/2007 | US20070032500 Therapeutic agents useful for treating pain |
| 02/08/2007 | US20070032497 Fused-ring compounds and use thereof as drugs |
| 02/08/2007 | US20070032490 N-Phenyl-'(4-pyridyl)-azinyl!amine derivatives as plant protection agents |
| 02/08/2007 | US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
| 02/08/2007 | US20070032487 Inhibitors of phosphatidylinositol 3-kinase |
| 02/08/2007 | US20070032478 Thiophene-2-carboxylic acid (4-{3-[(4-morpholin-4-yl-phenylamino)-methylene]-2-oxo-2,3-dihydro-1H-indole-6-carbonyl}-phenyl)-amide for modulating tyrosine kinase signal transduction to regulate, modulate and/or inhibit abnormal cell proliferation |
| 02/08/2007 | US20070032474 Use of a compound of formula 1 for making a pharmaceutical composition |
| 02/08/2007 | US20070032472 Reacting a 4-morpholinyl aniline with R-epichlorohydrin; carbonylating to form (a chloromethyloxazolidinone; reacting with potassium phthalimide or aziding; forming free amine with hydrazine hydate, which may be amidated with acetic anhydride; oxazolidinone and 3-chloro-2-hydroxypropyl intermediates |
| 02/08/2007 | US20070032434 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 02/08/2007 | US20070028962 Low molecular weight conjugated nitrogen compounds and devices fabricated using the same |
| 02/08/2007 | US20070028961 Organic dye compositions and use thereof in photovoltaic cells |
| 02/08/2007 | DE102005035575A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease |
| 02/08/2007 | CA2617413A1 2-aminoaryl pyridines as protein kinases inhibitors |
| 02/08/2007 | CA2617103A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2616937A1 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 02/08/2007 | CA2615890A1 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |
| 02/08/2007 | CA2615574A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/08/2007 | CA2614981A1 Antibacterial quinoline derivatives |
| 02/08/2007 | CA2613484A1 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 02/08/2007 | CA2612977A1 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 02/07/2007 | EP1749827A1 Anti-tumor agent |
| 02/07/2007 | EP1749006A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/07/2007 | EP1749001A1 3-piperidinylisochroman-5-ols as dopamine agonists |
| 02/07/2007 | EP1749000A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| 02/07/2007 | EP1748996A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug |
| 02/07/2007 | EP1748993A1 Compounds and compositions as ppar modulators |
| 02/07/2007 | EP1748991A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents |
| 02/07/2007 | EP1748987A2 2-propene-1-ones as hsp 70 inducers |
| 02/07/2007 | EP1748985A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 02/07/2007 | EP1748984A1 Piperidine derivatives as nk1 and nk3 antagonists |
| 02/07/2007 | EP1748983A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
| 02/07/2007 | EP1670773B1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| 02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/07/2007 | EP1185525B1 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 02/07/2007 | CN1910181A Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
| 02/07/2007 | CN1910179A Metallic complexes used as light-absorbent compounds in the information layer of optical data carriers |
| 02/07/2007 | CN1910178A Thiazole derivatives as A2B antagonists |
| 02/07/2007 | CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 02/07/2007 | CN1910165A Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors |
| 02/07/2007 | CN1910151A Cyclic amine derivative with heteroaryl ring |
| 02/07/2007 | CN1909909A 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept |
| 02/07/2007 | CN1907968A Method for making 4-(3,4-dichlorophenoxy)piperidine |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/07/2007 | CN1298710C Thiadiazole compounds and use thereof |
| 02/07/2007 | CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 02/07/2007 | CN1298704C Isatine derivatives with neurotrophic activity |
| 02/06/2007 | US7173137 Epothilone analogs |
| 02/06/2007 | US7173135 Substituted 3-cyanoquinolines as MEK inhibitors |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides |
| 02/06/2007 | US7173054 Respiratory syncytial virus replication inhibitors |
| 02/06/2007 | US7173051 Inhibitors of cathepsin S |
| 02/06/2007 | US7173048 Indolyl derivatives as liver-X-receptor (LXR) modulators |
| 02/06/2007 | US7173043 Heteroaromate OSC inhibitors |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 02/06/2007 | US7173034 Drugs for treatment of viral diseases such as Respiratory syncytial virus |
| 02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |